# A Study of Safety and Tolerability of NOX66 in Healthy Volunteers

> **NCT03780465** · PHASE1 · WITHDRAWN · sponsor: **Noxopharm Limited**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Oral idronoxil suspension
- **DRUG:** NOX66 (A)
- **DRUG:** NOX66 (B)

## Key facts

- **NCT ID:** NCT03780465
- **Lead sponsor:** Noxopharm Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decision to obtain PK data at a later date
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780465, "A Study of Safety and Tolerability of NOX66 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03780465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*